A phase I, open-label, single-dose, mass balance study of 14C-labeled abiraterone acetate in healthy male subjects

By Acharya Milin   Gonzalez Martha   Mannens Geert   De Vries Ronald   Lopez Christian   Griffin Thomas   Tran NamPhuong  

Xenobiotica, Vol. 43, Iss. 4, 2013-04 ,pp. : 379-389

Informa Healthcare

Access to resources Recommend Favorite

Evaluation of ASPIRE trial: a Phase III pivotal registration trial, using intracoronary administration of Generx (Ad5FGF4) to treat patients with recurrent angina pectoris

By Kaski Juan Carlos   Consuegra-Sanchez Luciano  

Expert Opinion on Biological Therapy, Vol. 13, Iss. 12, 2013-12 ,pp. : 1749-1753

Informa Healthcare

Access to resources Recommend Favorite

Prediction of Phase I single-dose pharmacokinetics using recombinant cytochromes P450 and physiologically based modelling

By Gibson C. R.   Bergman A.   Lu P.   Kesisoglou F.   Denney W. S.   Mulrooney E.  

Xenobiotica, Vol. 39, Iss. 9, 2009-09 ,pp. : 637-648

Informa Healthcare

Access to resources Recommend Favorite

Platinum(II) intercalators as potential anti-cancer agents

By Fisher D.M.   Fenton R.R.   Aldrich-Wright J.R.  

Journal of Inorganic Biochemistry, Vol. 96, Iss. 1, 2003-07 ,pp. : 131-131

Elsevier

Access to resources Recommend Favorite

Dose-response study and threshold estimation of griseofulvin-induced aneuploidy during female mouse meiosis I and II

By Marchetti Francesco  

Mutagenesis, Vol. 11, Iss. 2, 1996-03 ,pp. : 195-200

Oxford University Press

Access to resources Recommend Favorite